Priyanka Chopra has delivered some memorable hits during her Bollywood career spanning more than two decades. Recently, the ...

One of the leading dairy brands, Amul, has joined the ongoing debate over work-life balance that was triggered by L&T chairman SN Subrahmanyan's advocacy of 90-hour-work week. Meemansa Shekhawat ...

For years, the `916-billion Indian marketing industry has relied on an abundance of personal data to craft targeted campaigns, often without explicit user consent. Clearly, there was significant ...

(PTI) PM Narendra Modi on Saturday said there is a need to set up five-six more cooperatives like Amul to ensure better prices for farmers’ produce. Inaugurating the Grameen Bharat Mahotsav 2025 ...

The page will automatically reload. You may need to reload again if the build takes longer than expected. Hides preview environment warning banner on preview pages. Select a theme and theme mode ...

Vodafone Idea, the third largest telecom provider in India, has announced an exciting New Year gift for its 220 million customers. If you are a VI SIM user, there's good news in store for you.

Google is set to update its advertising policy on January 15 in a bid to combat financial scams, particularly those prevalent in the cryptocurrency sector. This move comes in response to numerous ...

India’s Jasprit Bumrah finished with a match haul of nine wickets in Melbourne against Australia in the fourth Test.(AP) Jasprit Bumrah has been a revelation for India in the ongoing Border ...

Indian banks are preparing for higher compliance costs, tighter margins, and tougher fee competition, potentially affecting 2025 earnings. Operational costs may stay high despite technology use. Banks ...

India's primary housing market is expected to see a modest single-digit price rise in 2025 amid increased supply and potential repo rate cuts. Industry experts are hopeful for government incentives, ...

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...